8357 Stock Overview
An investment holding company, operates medical clinics in Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Republic Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.11 |
| 52 Week High | HK$0.12 |
| 52 Week Low | HK$0.051 |
| Beta | 0.32 |
| 11 Month Change | 40.79% |
| 3 Month Change | 57.35% |
| 1 Year Change | 1.90% |
| 33 Year Change | -75.68% |
| 5 Year Change | -79.02% |
| Change since IPO | -86.46% |
Recent News & Updates
Shareholder Returns
| 8357 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 62.1% | -0.6% | 0.4% |
| 1Y | 1.9% | -23.3% | 12.0% |
Return vs Industry: 8357 exceeded the Hong Kong Healthcare industry which returned -23.3% over the past year.
Return vs Market: 8357 underperformed the Hong Kong Market which returned 12% over the past year.
Price Volatility
| 8357 volatility | |
|---|---|
| 8357 Average Weekly Movement | 17.5% |
| Healthcare Industry Average Movement | 8.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.9% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 8357's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 8357's weekly volatility has increased from 12% to 17% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 35 | n/a | republichealthcare.asia |
Republic Healthcare Limited, an investment holding company, operates medical clinics in Singapore. It offers consultation, medical investigation, and treatment services; and men and women’s sexual health services. The company provides its services through DTAP brand.
Republic Healthcare Limited Fundamentals Summary
| 8357 fundamental statistics | |
|---|---|
| Market cap | HK$66.77m |
| Earnings (TTM) | -HK$4.30m |
| Revenue (TTM) | HK$53.67m |
1.2x
P/S Ratio-15.5x
P/E RatioIs 8357 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8357 income statement (TTM) | |
|---|---|
| Revenue | S$9.27m |
| Cost of Revenue | S$6.74m |
| Gross Profit | S$2.53m |
| Other Expenses | S$3.27m |
| Earnings | -S$743.21k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0012 |
| Gross Margin | 27.27% |
| Net Profit Margin | -8.02% |
| Debt/Equity Ratio | 0% |
How did 8357 perform over the long term?
See historical performance and comparison